What If You Could Help ADHD Patients More Effectively?

*The Technology is non-invasive and certified safe to use even for all ages!

In fact, clinicians are concerned with the growing number of children diagnosed with ADHD worldwide! Attention is a real challenge for many children, even if they’re not diagnosed with attention challenges. Poor attention leads to poor memory, decision making and problem-solving, key functions when it comes to learning.

Clinical Trial Results

Neeuro’s Chief Scientist Cuntai Guan, who headed A*Star’s Biomedical Technology Research department, in collaboration with IMH and Duke-NUS, ran a clinical trial for Children with ADHD within the ages 6 to 12 years old.

Using a gamified intervention solution, “CogoLand”, the user concentrates/focus and the avatar in the game will move.

In the latest clinical trial that involved 172 ADHD children, the results showed that children who received 8 weeks of intervention showed more significant improvement in their inattentive symptoms than those who did not receive intervention.

Clinicians are concerned with the growing number of children diagnosed with ADHD worldwide! Attention is a real challenge for many children, even if they’re not diagnosed with attention challenges. Poor attention leads to poor memory, decision making and problem-solving, key functions when it comes to learning.

ADHD and Poor Focus

ADHD is a neurodevelopmental disorder that affects approximately two to 2 to 7% of children globally, with a growing number of cases in people aged 5 to 44 years worldwide.

Common symptoms represented by 38 to 57% of ADHD children include poor focus.

An epidemiological study of 20 countries from the World Health Organization found that across high-, upper–middle-, and low-/lower–middle-income countries, the mean worldwide prevalence of ADHD was ~2.2% overall in children and adolescents (aged <18 years).

The current management for ADHD includes medication and behavioural interventions where a clinician teaches both the parents and child strategies to reduce ADHD symptoms.

Clinical Trial Results

Neeuro’s Chief Scientist Cuntai Guan, who headed A*Star’s Biomedical Technology Research department, in collaboration with IMH and Duke-NUS, ran a clinical trial for Children with ADHD within the ages 6 to 12 years old.

Using a gamified intervention solution, “CogoLand”, the user concentrates/focus and the avatar in the game will move.

In the latest clinical trial that involved 172 ADHD children, the results showed that children who received 8 weeks of intervention showed more significant improvement in their inattentive symptoms than those who did not receive intervention.

• Clinically proven effective solution; 10 years in clinical trials.
• Non-invasive and safe technology that helps children with ADHD to focus longer.
• Breakthrough solution for parents who hesitate using medicines to treat children with ADHD.
• Fun and engaging for children.

SenzeBand

SenzeBand is Neeuro’s non-invasive EEG headband that safely measures brain signals. Low-frequency signals on the forehead are picked up by four individual sensors, giving us four individual channels of brain signals.

The level of these frequencies reveals a user’s brain states. SenzeBand measures the user’s mental state in real-time.

This helps in accessing, training, and tracking cognitive skills and brain performance. It measures and tracks your attention, focus, mental workload and relaxation. And if you can measure it… you can improve it!

The aim of the game is to move a character through a maze. Unlike most games where users use a gamepad or touchscreen, the character’s movements can only be controlled by brainwaves. By keeping the mind focused on the character, the character moves forward. A loss of focus results in the character slowing down or remaining stationary. At higher levels, the user also needs to hit a button on the touchscreen to make the character jump while moving at the same time.

SenzeBand

SenzeBand is Neeuro’s non-invasive EEG headband that safely measures brain signals. Low-frequency signals on the forehead are picked up by four individual sensors, giving us four individual channels of brain signals.

The level of these frequencies reveals a user’s brain states. SenzeBand measures the user’s mental state in real-time.

This helps in accessing, training, and tracking cognitive skills and brain performance. It measures and tracks your attention, focus, mental workload and relaxation. And if you can measure it… you can improve it!

CogoLand

CogoLand is a digital intervention solution based on Brain Computing Interface (BCI) technology developed at A*STAR’s Institute for Infocomm Research (I2R), as a result of a collaboration between IMH and Duke-NUS Medical School in Singapore. Neeuro licensed the technology that created CogoLand and developed it into a commercial product, which consists of the SenzeBand headband to track brain signals as well as the CogoLand mobile application.

The aim of the game is to move a character through a maze. Unlike most games where users use a gamepad or touchscreen, the character’s movements can only be controlled by brainwaves. By keeping the mind focused on the character, the character moves forward. A loss of focus results in the character slowing down or remaining stationary. At higher levels, the user also needs to hit a button on the touchscreen to make the character jump while moving at the same time.

Patients will be required to pair the CogoLand mobile application with a Neeuro SenzeBand for the detection of brainwaves. Machine learning algorithms will capture and interpret the mental states of patients based on their brainwaves, and these subsequently drive various challenges within the game.

The Team Behind Neeuro

This Is Why We Exist

This Is Why We Exist

Neeuro creates and develops innovations that empower people to live happier, healthier and more productive lives through the use of fun and effective learning methods. As a leading Digital Mental Health platform, we aim to utilise the technology to enable positive change in the ADHD healthcare sector.

Our therapeutic approach uses non-invasive brain computer interface (BCI) based games to treat children with ADHD symptoms. This patented solution was developed from over 10 years of research and clinical trials with various research institutes with an investment of over SGD $20 million / INR 100 crores. As each child may present with different ADHD related behaviours, it is important for parents to speak with a mental health professional to discuss the treatment options.

We believe that by offering these programs, you will be empowered to strengthen the areas that patients are weak and make sessions more enjoyable, meaningful and purposeful.

� Can the improvements/changes be seen throughout the rest of the child’s life or does it only have a short effect?

In the latest clinical trial using CogoLand, the intervention programme was done with children at several phases: 8-weeks of intensive training followed by maintenance training (3 sessions per month) over the course of 12 weeks. The researchers saw that Brain-Computer Interface (BCI)-based attention training programme can lessen ADHD symptoms and maintenance training may sustain these improvements.

� Some parents are concerned with children using their gadgets and their screen time effects. Would the CogoLand sessions negatively impact their child’s screen time?

We are very much conscious about concerns over screen time. In CogoLand, the sessions are monitored and limited to 20 minutes. This ensures that we are only using the device to achieve the goal of getting the child to improve and sustain their attention level.